It has been demonstrated that STAT3 plays critical roles in migration, proliferation, epithelial-to-mesenchymal transition (EMT), and chemoresistance, making the STAT3 signaling pathway a desirable target for breast cancer [12]. Here, STAT3 is linked to breast cancer.